CT血管造影用于急性轻型卒中患者分诊的成本效果分析
本研究用Markov决策分析模型从社会视角评估急性轻型卒中(NIHSS评分≤6)患者采用CT血管造影筛查大血管闭塞的成本效果。结果显示,CT血管造影后立即取栓的成本最低(346 007美元)且健康获益最高(9.26 QALYs);不做血管影像的成本最高且健康获益最低。当大血管闭塞概率大于0.16%时,CT血管造影具有成本效果。
要点
- 急性轻型卒中(NIHSS≤6)患者中,CT血管造影筛查大血管闭塞并立即取栓的成本最低且健康获益最高。
- 不做血管影像导致未检出的大血管闭塞,健康结局更差且成本更高。
- 当大血管闭塞概率大于0.16%时,CT血管造影具有成本效果。
核心结论
- 在急性轻型卒中患者中用CT血管造影筛查大血管闭塞具有成本效果,并与更好的健康结局相关。
- 不做血管影像时未检出的大血管闭塞导致更差的健康结局和更高的成本。
研究设计与样本
- 研究采用Markov决策分析模型,从社会视角构建。
- 评估三种管理策略:不做血管影像并最佳药物治疗;所有患者行CT血管造影并在静脉溶栓后对有大血管闭塞者立即取栓;所有患者行CT血管造影并最佳药物治疗(包括静脉溶栓,对有大血管闭塞且神经功能恶化者行补救性取栓)。
- 进行了单因素、双因素和概率敏感性分析。
诊断标准与关键数值
- 基础病例计算显示,CT血管造影后立即取栓的成本最低(346 007美元)且健康获益最高(9.26质量调整生命年[QALYs])。
- CT血管造影后最佳药物治疗并对有大血管闭塞者可能行补救性取栓的成本稍高(346 500美元)且健康获益较低(9.09 QALYs)。
- 不做血管影像的成本最高且健康获益最低;与CT血管造影后立即取栓策略相比,健康获益差异为0.39 QALY,相当于每例患者142天完全健康状态。
- 概率敏感性分析中结论稳健;当急性轻型卒中患者大血管闭塞概率大于0.16%时,CT血管造影具有成本效果。
- 行CT血管造影的净货币效益在较年轻患者中更高:55岁患者中CT血管造影后立即取栓与不做血管影像的差异为68 950美元,而85岁患者中为20 931美元。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Minor stroke is common and may represent up to two-thirds of cases of acute ischemic stroke. The cost-effectiveness of CT angiography in patients with minor stroke (National Institutes of Health Stroke Scale [NIHSS] score ≤6) is not well established. Purpose To evaluate cost-effectiveness of CT angiography in the detection of large-vessel occlusion (LVO) in patients with acute minor stroke (NIHSS score ≤6). Materials and Methods A Markov decision-analytic model with a societal perspective was constructed. Three different management strategies were evaluated: (a) no vascular imaging and best medical management, (b) CT angiography for all patients and immediate thrombectomy for LVO after intravenous thrombolysis, and (c) CT angiography for all and best medical management (including intravenous thrombolysis, with rescue thrombectomy for patients with LVO and neurologic deterioration). One-way, two-way, and probabilistic sensitivity analyses were performed. Results Base-case calculation showed that CT angiography followed by immediate thrombectomy had the lowest cost ($346 007) and highest health benefits (9.26 quality-adjusted life-years [QALYs]). CT angiography followed by best medical management with possible rescue thrombectomy for patients with LVO had a slightly higher cost ($346 500) and lower health benefits (9.09 QALYs). No vascular imaging had the highest cost and lowest health benefits. The difference in health benefits compared with the CT angiography and immediate thrombectomy strategy was 0.39 QALY, which corresponds to 142 days in perfect health per patient. The conclusion was robust in a probabilistic sensitivity analysis. CT angiography was cost-effective when the probability of LVO was greater than 0.16% in patients with acute minor stroke. The net monetary benefit of performing CT angiography was higher in younger patients ($68 950 difference between CT angiography followed by immediate thrombectomy and no vascular imaging in 55-year-old patients compared with $20 931 in 85-year-old patients). Conclusion Screening for large-vessel occlusion with CT angiography in patients with acute minor stroke is cost-effective and associated with improved health outcomes. Undetected large-vessel occlusion in the absence of vascular imaging results in worse health outcomes and higher costs. © RSNA, 2020 Online supplemental material is available for this article.
引用
- Wu X, Hughes DR, Gandhi D, et al. CT Angiography for Triage of Patients with Acute Minor Stroke: A Cost-effectiveness Analysis. Radiology. 2020. PMID: 31934828. doi:10.1148/radiol.2019191238
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。